{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:23:46Z","timestamp":1760549026660,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1124\/jpet.110.172981","type":"journal-article","created":{"date-parts":[[2010,11,6]],"date-time":"2010-11-06T01:53:26Z","timestamp":1289008406000},"page":"506-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Distribution of Nifurtimox Across the Healthy and Trypanosome-Infected Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers"],"prefix":"10.1016","volume":"336","author":[{"given":"Sinthujah","family":"Jeganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Dogruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Croft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.172981_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.1987.36.46","article-title":"Effects of the ornithine decarboxylase inhibitors dl-\u03b1-difluoromethylornithine and \u03b1-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models","volume":"36","author":"Bacchi","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/jpet.110.172981_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.38.3.563","article-title":"Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using dl-\u03b1-difluoromethylornithine and standard trypanocides","volume":"38","author":"Bacchi","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.110.172981_bib3","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/jm050177+","article-title":"Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites","volume":"48","author":"Baliani","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.110.172981_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/510534","article-title":"Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness","volume":"195","author":"Bisser","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1124\/jpet.110.172981_bib5","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: a case series","volume":"1","author":"Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1124\/jpet.110.172981_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4269\/ajtmh.1984.33.1073","article-title":"New drug combination for experimental late-stage African trypanosomiasis: dl-\u03b1-difluoromethylornithine (DFMO) with suramin","volume":"33","author":"Clarkson","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/jpet.110.172981_bib7","first-page":"1617","article-title":"Investigations on the pharmacokinetics of nifurtimox-35 S in the rat and dog","volume":"22","author":"Duhm","year":"1972","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.110.172981_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/adc.2008.157297","article-title":"Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis","volume":"95","author":"Garcia-Bournissen","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1124\/jpet.110.172981_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.0022-3042.2001.00711.x","article-title":"The distribution of the anti-HIV drug, 2\u20323\u2032-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors","volume":"80","author":"Gibbs","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.172981_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1471-4159.2003.01560.x","article-title":"Mechanisms by which 2\u2032,3\u2032-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy","volume":"84","author":"Gibbs","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.172981_bib11","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(92)90161-H","article-title":"A specific enzyme assay for aminopeptidase M in rat brain","volume":"51","author":"Gillespie","year":"1992","journal-title":"Life Sci"},{"key":"10.1124\/jpet.110.172981_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00265935","article-title":"The pharmacokinetics of nifurtimox in chronic renal failure","volume":"42","author":"Gonz\u00e1lez-Martin","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.110.172981_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1645\/GE-287R","article-title":"African trypanosome interactions with an in vitro model of the human blood-brain barrier","volume":"90","author":"Grab","year":"2004","journal-title":"J Parasitol"},{"key":"10.1124\/jpet.110.172981_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1006\/bbrc.1997.8132","article-title":"Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells","volume":"243","author":"Huai-Yun","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.110.172981_bib15","first-page":"147","article-title":"Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes","volume":"7","author":"Jennings","year":"1983","journal-title":"Contrib Microbiol Immunol"},{"key":"10.1124\/jpet.110.172981_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1383-5769(02)00044-2","article-title":"Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen","volume":"51","author":"Jennings","year":"2002","journal-title":"Parasitol Int"},{"key":"10.1124\/jpet.110.172981_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1248\/jhs.51.101","article-title":"Lack of contribution of P-glycoprotein (P-gp) to transport via the mouse blood-cerebrospinal fluid barrier","volume":"51","author":"Lee","year":"2005","journal-title":"J Health Sci"},{"key":"10.1124\/jpet.110.172981_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172981_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actatropica.2007.07.007","article-title":"Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate","volume":"104","author":"Maina","year":"2007","journal-title":"Acta Trop"},{"key":"10.1124\/jpet.110.172981_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0035-9203(93)90044-Q","article-title":"Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness","volume":"87","author":"Milord","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/jpet.110.172981_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(02)00238-2","article-title":"Nifurtimox biotransformation to reactive metabolites or nitrite in liver subcellular fractions and model systems","volume":"136","author":"Montalto de Mecca","year":"2002","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.110.172981_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(24)29490-8","article-title":"Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells","volume":"298","author":"Morita","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.172981_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0305-1846.2001.00306.x","article-title":"Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model","volume":"27","author":"Mulenga","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1124\/jpet.110.172981_bib24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/315322","article-title":"Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines","volume":"181","author":"Namangala","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1124\/jpet.110.172981_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0035-9203(89)90642-1","article-title":"Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil","volume":"83","author":"Neal","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/jpet.110.172981_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI27798C1","article-title":"Erratum","volume":"118","author":"Nikolskaia","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.110.172981_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0035-9203(92)90298-Q","article-title":"High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire","volume":"86","author":"P\u00e9pin","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/jpet.110.172981_bib28","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"10.1124\/jpet.110.172981_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/jpet.110.172981_bib30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo","volume":"45","author":"Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1124\/jpet.110.172981_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-4159.2008.05706.x","article-title":"The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain","volume":"107","author":"Sanderson","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.172981_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/jpet.108.149872","article-title":"Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein","volume":"329","author":"Sanderson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.172981_bib33","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.00372-07","article-title":"Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice","volume":"51","author":"Sanderson","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.110.172981_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jnr.490210109","article-title":"Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia","volume":"21","author":"Schultzberg","year":"1988","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.110.172981_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2005.11.011","article-title":"Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier","volume":"138","author":"Soontornmalai","year":"2006","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.110.172981_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(24)36674-1","article-title":"Structure-activity relationships of a series of [d-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability","volume":"281","author":"Thomas","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.172981_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0005-2736(02)00445-5","article-title":"Functional characterization of the mouse organic-anion-transporting polypeptide 2","volume":"1564","author":"van Montfoort","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.110.172981_bib38","first-page":"871","article-title":"The determination of pentamidine (4,4\u2032-diamidinophenoxypentane) in plasma, urine, and tissues","volume":"75","author":"Waalkes","year":"1970","journal-title":"J Lab Clin Med"},{"key":"10.1124\/jpet.110.172981_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/519745","article-title":"Randomized, controlled trial of treatments for second-stage sleeping sickness","volume":"196","author":"Woodrow","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1124\/jpet.110.172981_bib40","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524462289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524462289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.172981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:25:07Z","timestamp":1740018307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524462289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0022356524462289"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.172981","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Distribution of Nifurtimox Across the Healthy and Trypanosome-Infected Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.172981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}